A study to evaluate the safety, tolerance and changes in blood levels of an anti-toxin drug (FBT-002) in healthy male and female subjects
Phase 1
Recruiting
- Conditions
- AntidoteMedDRA version: 20.0Level: LLTClassification code: 10015711Term: Exposure to poisonous plant Class: 10022117Therapeutic area: Not possible to specify
- Registration Number
- CTIS2023-505745-16-00
- Lead Sponsor
- Eurofins Optimed
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: ;Secondary Objective: ;Primary end point(s):
- Secondary Outcome Measures
Name Time Method